Kalaris Therapeutics, Inc.
KLRS
Revenue
165.00k
▲165.00k∞%
-Assets
81.18M
▼-11.67M▼-12.57%
3 Months ChangeLiabilities
39.31M
▼-417.00k▼-1.05%
3 Months ChangeFree Cash Flow
-19.00M
▼-19.00M-∞%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-09
Form 8-K
ID: 0001193125-26-097548
2025-12-18
Form 8-K
ID: 0001193125-25-323706
2025-12-17
Form 8-K
ID: 0001193125-25-322950
2025-11-12
Form 10-Q
ID: 0001193125-25-277464
2025-11-12
Form 8-K
ID: 0001193125-25-276060
2025-11-03
Form 8-K
ID: 0001193125-25-261697
2025-08-13
Form 10-Q
ID: 0000950170-25-107979
2025-08-13
Form 8-K
ID: 0001193125-25-179466
2025-08-13
Form 8-K
ID: 0001193125-25-179464
2025-06-20
Form 8-K
ID: 0001193125-25-143202